Protocol for the saMS trial (supportive adjustment for multiple sclerosis): A randomized controlled trial comparing cognitive behavioral therapy to supportive listening for adjustment to multiple sclerosis

BMC Neurology

Volumn 9, Issue , 2009, Pages 45-

  Moss Morris, Rona ^a   Dennison, Laura ^a   Yardley, Lucy ^a   Landau, Sabine ^b   Roche, Suzanne ^c   McCrone, Paul ^b   Chalder, Trudie ^b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISTRESS SYNDROME; ECONOMIC EVALUATION; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; INTERVENTION STUDY; INTERVIEW; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIPLE SCLEROSIS; NATIONAL HEALTH SERVICE; PARALLEL DESIGN; PREDICTION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; ROLE STRESS; SELF REPORT; SOCIAL DISABILITY; SOCIAL PSYCHOLOGY; SOCIAL STRESS; SUPPORTIVE LISTENING; THERAPY; TREATMENT RESPONSE; ADULT; COST BENEFIT ANALYSIS; DAILY LIFE ACTIVITY; ECONOMICS; PATIENT SELECTION; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SOCIAL ADAPTATION; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADULT; COGNITIVE THERAPY; COST-BENEFIT ANALYSIS; HUMANS; MULTIPLE SCLEROSIS; PATIENT SELECTION; QUALITY OF LIFE; QUESTIONNAIRES; SOCIAL ADJUSTMENT; TREATMENT OUTCOME;

EID: 70349566154     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-9-45     Document Type: Article

References (62)

1. Robinson I. Multiple Sclerosis 1988, London: Routledge.
2. National MS Society Who gets MS?. 2009, , http://www.nationalmssociety.org/about-multiple-sclerosis/who-gets-ms/in dex.aspx
3. UK MS Society What is MS?. 2009, , http://www.mssociety.org.uk/about_ms/what_is_ms/index.html
4. Hakim EA, Bakheit AMO, Bryant TN, Roberts MWH, McIntosh-Michaelis SA, Spackman AJ, Martin JP, McLellan DL. The social impact of multiple sclerosis-a study of 305 patients and their relatives. Disability and Rehabilitation 2000, 22:288-293. 10.1080/096382800296755, 10864132.
5. Janssens A, van Dorn P, de Boer J, Meche F, Passchier J, Hintzen R. Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners. Acta Neurologica Scandinavica 2003, 108:389-395. 10.1034/j.1600-0404.2003.00166.x, 14616290.
6. Patten SC, Metz LM. Depression in Multiple Sclerosis. Psychotherapy and Psychosomatics 1997, 66:286-292.
7. Siegert RJ, Abernethy DA. Depression in multiple sclerosis: a review. Journal of Neurology, Neurosurgery and Psychiatry 2005, 76:469-475.
8. Zorzon M, de Masi R, Nasuelli D, Ukmar M, Pozzi Mucelli R, Cazzato G, Bratina A, Zivadinov R. Depression and anxiety in Multiple Sclerosis: a clinical and MRI study in 95 subjects. Journal of Neurology 2001, 248:1432-1459.
9. Benito-Leon J, Morales MJ, Rivera-Navarro J, Mitchell A. A review about the impact of multiple sclerosis on health-related quality of life. Disability and Rehabilitation 2003, 25:1291-1304. 10.1080/09638280310001608591, 14617435.
10. Mohr DC, Dick PP, Russo D, Pinn J, Boudewyn AC, Likosky W, Goodkin DE. The Psychosocial Impact of Multiple Scleoris: Exploring the Patient's Perspective. Health Psychology 1999, 18:376-382. 10.1037/0278-6133.18.4.376, 10431939.
11. Antonak RF, Livneh H. Psychosocial adaptation to disability and its investigation among persons with multiple sclerosis. Social Science and Medicine 1995, 40:1099-1108. 10.1016/0277-9536(94)00167-R, 7597463.
12. Brooks NA, Matson RR. Social-psychological adjustment to multiple sclerosis. A longitudinal study. Social Science & Medicine 1982, 16:2129-2135.
13. Chwastiak L, Ehde DM, Gibbons LE, Sullivan M, Bowen JD, Kraft GH. Depressive symptoms and severity of illness in multiple sclerosis: Epidemiologic study of a large community sample. Am J Psychiatry 2002, 159:1862-1868. 10.1176/appi.ajp.159.11.1862, 12411220.
14. McIvor G, Rikland M, Reznikoff M. Depression in multiple sclerosis as a function of length and severity of illness, age, remissions, and perceived social support. Journal of Clinical Psychology 1984, 40:1028-1033. 10.1002/1097-4679(198407)40:4<1028::AID-JCLP2270400427>3.0.CO;2-1, 6480837.
15. Thomas PW, Thomas S, Hiller C, Galvin K, Baker R. Psychological interventions for multiple sclerosis. Cochrane Database of Systematic Reviews 2006, 1:CD004431.
16. Dennison L, Moss-Morris R, Chalder T. A review of psychological correlates of adjustment in patients with multiple sclerosis. Clinical Psychology Review 2009, 29:141-153. 10.1016/j.cpr.2008.12.001, 19167801.
17. McCabe MP, McKern S, McDonald E. Coping and psychological adjustment among people with multiple sclerosis. Journal of Psychosomatic Research 2004, 56:355-361. 10.1016/S0022-3999(03)00132-6, 15046974.
18. Schwartz C, Frohner R. Contribution of demographic, medical, and social support variables in predicting the mental health dimension of quality of life among people with multiple sclerosis. Health Soc Work 2005, 30:203-212.
19. de Ridder D, Schreurs K, Bensing J. The relative benefits of being optimistic: Optimism as a coping resource in multiple sclerosis and Parkinson's disease. British Journal of Health Psychology 2000, 5:141-155.
20. Patten SB, Metz LM. Hopelessness ratings in relapsing-remitting and secondary progressive multiple sclerosis. International Journal of Psychiatry in Medicine 2002, 32:155-165. 10.2190/K05D-XER3-WT4Y-FDQV, 12269596.
21. Stuifbergen AK, Blozis SA, Harrison TC, Becker HA. Exercise, functional limitations, and quality of life: A longitudinal study of persons with multiple sclerosis. Archives of Physical Medicine & Rehabilitation 2006, 87:935-943.
22. Aikens JE, Fischer JS, Namey M, Rudick RA. A replicated prospective investigation of life stress, coping, and depressive symptoms in multiple sclerosis. Journal of Behavioral Medicine 1997, 20:433-445. 10.1023/A:1025547431847, 9415854.
23. Pakenham KI. Adjustment to multiple sclerosis: application of a stress and coping model. Health Psychology 1999, 18:383-392. 10.1037/0278-6133.18.4.383, 10431940.
24. Bruce JM, Polen D, Arnett PA. Pain and affective memory biases interact to predict depressive symptoms in multiple sclerosis. Multiple Sclerosis 2007, 13:58-66. 10.1177/1352458506070229, 17294612.
25. Kneebone II, Dunmore EC, Evans E. Symptoms of depression in older adults with multiple sclerosis (MS): comparison with a matched sample of younger adults. Aging & Mental Health 2003, 7:182-185. 10.1080/1360786031000101148, 12775398.
26. Shnek ZM, Foley FW, LaRocca NG, Gordon WA, DeLuca J, Schwartzman HG, Halper J, Lennox S, Irvine J. Helplessness, self-efficacy, cognitive distortions, and depression in multiple sclerosis and spinal cord injury. Annals of Behavioral Medicine 1997, 19:287-294. 10.1007/BF02892293, 9603703.
27. Mohr D, Likosky W, Bertagnolli A, Goodkin D, Wende J, Dwyer P, Dick L. Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis. Journal of Consulting and Clinical Psychology 2000, 68:356-361. 10.1037/0022-006X.68.2.356, 10780138.
28. Mohr D, Boudewyn A, Goodkin D, Bostrom A, Epstein L. Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and Sertraline for the treatment of depression in multiple sclerosis. Journal of Consulting and Clinical Psychology 2001, 69:942-949. 10.1037/0022-006X.69.6.942, 11777121.
29. Mohr D, Hart S, Julian L, Catledge C, Honos-Webb L, Vella L, Tasch E. Telephone-administered psychotherapy for depression. Archives of General Psychiatry 2005, 62:1007-1014. 10.1001/archpsyc.62.9.1007, 16143732.
30. Malcomson KS, Dunwoody L, Lowe-Strong AS. Psychosocial interventions in people with multiple sclerosis: a review. Journal of Neurology 2007, 254:1-13. 10.1007/s00415-006-0349-y, 17508135.
31. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gotzsche PC, Lang T, . for the CONSORT Group The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med 2001, 134:663-694.
32. Kurtzke J. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983, 33:1444-1452.
33. Brandt J, Welsh K, Breitner J, Folstein M, Helms M, Christian J. Hereditary influences on cognitive functioning in older men; a study of 4000 pairs. Archives of Neurology 1993, 50:599-603.
34. Godfrey E, Chalder T, Ridsdale L, Seed P, Ogden J. Investigating the 'active ingredients' of cognitive behaviour therapy and counselling for patients with chronic fatigue in primary care: developing a new process measure to assess treatment fidelity and predict outcome. British Journal of Clinical Psychology 2007, 46:253-272. 10.1348/014466506X147420, 17697477.
35. Beck AT. Cognitive therapy and the emotional disorders 1976, New York: Penguin Books.
36. Hayes SC, Follette VM, Lineham M. Mindfulness and acceptance: Expanding the cognitive behavioral tradition 2004, New York: The Guilford Press.
37. Bogosian A, Moss-Morris R, Yardley L, Dennison L. Experiences of partners of people in the early stages of multiple sclerosis. Multiple Sclerosis 2009, 15:876-884. 10.1177/1352458508100048, 19168601.
38. Risdale L, Godfrey E, Chalder T, Seed P, King M, Wallace P, Wessely S. Chronic fatigue in general practice: is counselling as good as cognitive behaviour therapy? A UK randomised trial. British Journal of General Practice 2001, 51:19-24. 1313894, 11271868.
39. Wearden AJ, Riste L, Dowrick C, Chew-Graham C, Bentall RP, Morriss RK, Peters S, Dunn G, Richardson G, Lovell K. Fatigue Intervention by Nurses Evaluation - The FINE Trial. A randomised controlled trial of nurse led self-help treatment for patients in primary care with chronic fatigue syndrome: study protocol. [ISRCTN74156610]. BMC Medicine 2006, 4:9. 1456982, 16603058, 10.1186/1741-7015-4-9.
40. Rogers C. Client-centered therapy: its current practice, implications and theory 1951, London: Constable.
41. Goldberg D. General Health Questionnaire (GHQ-12). 1992, Windsor, NFER-NELSON.
42. Hobart J, Riazi A, Lamping D, Fitzpatrick R, Thompson A. How responsive is the Multiple Sclerosis Impact Scale (MSIS-29)? A comparison with some other self report scales. Journal of Neurology Neurosurgery and Psychiatry 2006, 76:1539.
43. Mundt J, Marks I, Shear K, Greist J. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. British Journal of Psychiatry 2002, 180:461-464. 10.1192/bjp.180.5.461, 11983645.
44. Curtis L, Netten A. Unit costs of health and social care 2006, Canterbury: PSSRU.
45. Stuifbergen A. Conceptualization and development of the Acceptance of Chronic Health Conditions Scale. Issues in Mental Health Nursing 2008, 29:101-114. 10.1080/01612840701792548, 18293219.
46. Sinclair VG, Wallston KA. The development and validation of the Psychological Vulnerability Scale. Cognitive Therapy and Research 1999, 23:119-129.
47. Jopson NM, Moss-Morris R. The role of illness severity and illness representations in adjusting to multiple sclerosis. Journal of Psychosomatic Research 2003, 54:503-511. 10.1016/S0022-3999(02)00455-5, 12781303.
48. Broadbent E, Petrie KJ, Main J, Weinman J. The Brief Illness Perception Questionnaire. Journal of Psychosomatic Research 2006, 60:631-637. 10.1016/j.jpsychores.2005.10.020, 16731240.
49. Power M, Champion LA, Aris SJ. The development of a measure of social support: The Significant Others (SOS) Scale. Br J Clin Psychol 1988, 27:349-358.
50. Bowen J, Gibbons L, Gianas A, Kraft G. Self-administered Expanded Disability Status Scale with functional system scores correlates well with physician-administered test. Multiple Sclerosis 2001, 7:201-206.
51. Beecham J, Knapp M. Costing psychiatric interventions. Measuring mental health needs 2001, London: Gaskell, Thornicroft G.
52. Williams A. The role of the EuroQol instrument in QALY calculations. 1995, University of York, Centre for Health Economics.
53. Boutron I, Moher D, Altman D, Schulz K, Ravaud P. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: Explanation and Elaboration. Ann Intern Med 2008, 148:295-310.
54. Carpenter J, Kenward MG, White IR. Sensitivity analysis after multiple imputation under missing at random: a weighting approach. Statistical Methods in Medical Research 2007, 16:259-275. 10.1177/0962280206075303, 17621471.
55. Baron R, Kenny D'. The moderator-mediator variable distinction in social psychological research: conceptual, strategic and statistical considerations. Journal of Personality and Social Psychology 1986, 51:1173-1182. 10.1037/0022-3514.51.6.1173, 3806354.
56. Dunn G, Bentall R. Modelling treatment effect heterogeneity in randomised controlled trials of complex interventions (psychological treatments). Statistics in Medicine 2007, 26:4709-4745.
57. Emsley R, White I, Dunn G. Mediation and moderation of treatment effects in randomised controlled trials of complex interventions. Statistical Methods in Medical Reserach 2009,
58. Williams P. The psychopathology of self-assessed health: a cognitive approach to health anxiety and hypochondriasis. Cognitive Therapy and Research 2004, 28:629-644.
59. Boyatzis RE. Transforming Qualitative Information 1998, Thousand Oaks, CA: Sage Publications.
60. Joffe H, Yardley L. Content and Thematic Analysis. Research Methods for Clinical and Health Psychology 2000, London: Sage, Marks D, Yardley L.
61. Charmaz K. Constructing Grounded Theory: A Practical Guide Through Qualitative Analysis 2006, London: Sage.
62. Glaser BG, Strauss SA. Discovery of Grounded Theory. Strategies for Qualitative Resarch 1967, New York: Aldine.